Follow The Filings

IRTC iRhythm

iRhythm earnings company data as of 10:00 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 0.02 — —
Rev — — —

Insider trades

Open-market buys and sales by IRTC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IRTC insider trades
  • $57K bought by 1 insider
  • None no sales outside a trading plan
  • $4.5M sold by 5 insiders under 10b5-1 plans
  1. Abhijit Y Talwalkar Director
    Planned sale
    $626K 5,312 shares at $117.93 21% of stake
    Traded May 11 Filed May 12
  2. Abhijit Y Talwalkar Director
    Buy
    $57K 5,312 shares at $10.71 +26% to stake
    Traded May 11 Filed May 12
  3. Mervin Smith EVP Strategic Business Ops
    Planned sale
    $295K 2,585 shares at $114.30 10% of stake
    Traded Mar 16 Filed Mar 17
  4. Mervin Smith EVP Strategic Business Ops
    Planned sale
    $103K 732 shares at $140.91 4.6% of stake
    Traded Feb 24 Filed Feb 25
  5. Marc Wade Rosenbaum Chief Accounting Officer
    Planned sale
    $39K 280 shares at $140.91 2.6% of stake
    Traded Feb 24 Filed Feb 25
  6. Abhijit Y Talwalkar Director
    Planned sale
    $774K 5,312 shares at $145.70 21% of stake
    Traded Feb 23 Filed Feb 24
  7. Chad Patterson Chief Comm & Product Officer
    Planned sale
    $52K 280 shares at $184.83 0.6% of stake
    Traded Dec 2, 2025 Filed Dec 3, 2025
  8. Abhijit Y Talwalkar Director
    Planned sale
    $925K 5,312 shares at $174.13 21% of stake
    Traded Nov 10, 2025 Filed Nov 12, 2025
  9. Daniel G. Wilson CFO
    Planned sale
    $1.7M 8,000 shares at $207.44 23% of stake
    Traded Oct 31, 2025 Filed Nov 3, 2025

Also filed in the last 12 months, not counted as buying or selling: 46 sales to cover taxes, 40 stock grants, and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
8-K 7.01,9.01
8-K 7.01
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 5.02
8-K 1.01,2.02,7.01,9.01
8-K 1.01,3.02,9.01
10-Q
8-K 1.05
8-K 7.01,9.01
8-K 5.02,5.07,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.